Abivax (AAVXF) Retained Earnings (2022 - 2025)

Abivax has reported Retained Earnings over the past 4 years, most recently at -$391.2 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$391.2 million for Q4 2025, down 39.4% from a year ago — trailing twelve months through Dec 2025 was -$391.2 million (down 39.4% YoY), and the annual figure for FY2025 was -$379.7 million, down 33.59%.
  • Retained Earnings for Q4 2025 was -$391.2 million at Abivax, down from -$280.7 million in the prior quarter.
  • Over the last five years, Retained Earnings for AAVXF hit a ceiling of -$62.0 million in Q4 2022 and a floor of -$391.2 million in Q4 2025.
  • Median Retained Earnings over the past 4 years was -$213.1 million (2023), compared with a mean of -$219.8 million.
  • Biggest five-year swings in Retained Earnings: crashed 134.75% in 2023 and later tumbled 39.4% in 2025.
  • Abivax's Retained Earnings stood at -$62.0 million in 2022, then tumbled by 134.75% to -$145.5 million in 2023, then crashed by 92.92% to -$280.7 million in 2024, then crashed by 39.4% to -$391.2 million in 2025.
  • The last three reported values for Retained Earnings were -$391.2 million (Q4 2025), -$280.7 million (Q4 2024), and -$145.5 million (Q4 2023) per Business Quant data.